Clinical Trial

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to identify and study changes in muscle in people with facioscapulohumeral muscular dystrophy using magnetic resonance imaging and spectroscopy.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06 -> 2028-06 2026-08-06
minor Completion pushed: 2026-06 -> 2028-06 2026-08-06
Trial Details
NCT Number NCT01671865
Lead Sponsor Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Conditions Facioscapulohumeral Muscular Dystrophy
Enrollment 75 participants
Start Date 2012-03
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-05